IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Merck & Co., Inc.

Portfolio Profile

CIK: 0000310158 | RAHWAY, NJ

Investment Profile

Style

Growth

Turnover

Low

Orientation

Concentrated long-term
$526.4M
AUM
13
Positions
99.79%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Personalis Inc(PSNL)14,044,943$188.2M35.75%
2Moderna Inc(MRNA)2,308,190$161.6M30.71%
3Kymera Therapeutics Inc(KYMR)772,165$88.5M16.82%
4Aktis Oncology Inc(AKTS)952,844$30.7M5.83%
5Eikon Therapeutics Inc(EIKN)1,666,666$21.7M4.13%
6

Sector Allocation

Latest filing, equity positions only

Healthcare99.81% · $525.4M
Unclassified0.19% · $1.0M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare90.23%99.81%+9.58%
Unclassified9.77%0.19%-9.58%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$258.0M | 13 pos.
$164.3M | 12 pos.
$215.6M | 13 pos.
$228.0M | 13 pos.
$349.4M | 14 pos.
$526.4M | 13 pos.
Entrada Therapeutics Inc(TRDA)
1,739,768
$12.8M
2.43%
7Sutro Biopharma Inc(STRO)272,351$9.0M1.72%
8Alector Inc(ALEC)3,545,719$7.1M1.35%
9Evaxion Biotech A/S(EVAX)1,214,126$3.8M0.71%
10Viridian Therapeutics Inc(VRDN)93,414$1.7M0.33%
Cap SizePrev %Curr %Change
Small Cap30.48%45.74%+15.26%
Large Cap33.56%30.71%-2.85%
Mid Cap18.93%17.15%-1.78%
Micro Cap7.26%6.22%-1.04%
Unclassified9.77%0.19%-9.58%
Q4
24
Q1
25
Q2
25
Q3
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

3
New
4
Closed
0
Increased
0
Decreased
10
Unchanged